Lotte Steuten is co-author on a new paper regarding Molecular Diagnostics, published by Public Health Genomics. The paper, with Juliette Plun-Favreau as first author, discusses the necessary evolutions in policy and health technology assessment to ensure that patients can have equal access to appropriate molecular diagnostics.

The article considers the perspectives of different stakeholders (patients, health care payers, health care professionals, and manufacturers) on the provision of a research-enabled, patientfocused molecular diagnostics platform that supports optimal patient care.

The full article can be found here.